Datasheet
Clinical Decision Support
Providers
Medication safety
How can Micromedex support patient safety around polypharmacy in older populations?
If polypharmacy rates increase in line with the current expectations, it is highly likely that more elderly people will be at risk of avoidable harm in the future. Read 3 ways that Micromedex can support patient safety and help reduce the risks of polypharmacy in older populations.
Related Documents
Client Newsletter
Micromedex Newsletter, December edition
In this December edition we reflect on the evolution of Micromedex in 2024 and look ahead to what’s coming next. Read about key Micromedex milestones this year, including ...
Client Newsletter
Micromedex Newsletter, September edition
In this September edition we spotlight patient safety, featuring articles on reducing medication-related harm, preventing avoidable harm in vulnerable populations, and ...
Client Newsletter
Micromedex Newsletter, June edition
In this June edition, read all about Sonika Mathur, the new leader of Micromedex. Find details of the latest enhancements around pediatrics, product navigation and IV ...